NCT02005237

Brief Summary

Cognitive dysfunction is frequent in patients with multiple sclerosis (MS) and to date, there are no available treatments to improve cognition in this patient population. Some evidence from animal studies and small clinical trials suggest that aerobic exercise might beneficially affect cognitive function in MS. The aim of this randomized-controlled trial is to explore if an aerobic exercise training program can enhance cognition in MS. In addition, we will employ neuroimaging markers to determine if exercise alters measures of brain structure and function. Patients will be randomly assigned to either a 3-months exercise program (bicycle ergometry, 2-3 session per week) or a waitlist control group. The primary endpoint of the study is a test of verbal learning and memory. Secondary endpoints include neuroimaging markers of functional and structural connectivity in the brain. We hypothesize that exercise will improve verbal learning and memory and beneficially affect measures of brain connectivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Dec 2013

Typical duration for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

December 3, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 9, 2013

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
Last Updated

June 26, 2017

Status Verified

June 1, 2017

Enrollment Period

2.4 years

First QC Date

December 3, 2013

Last Update Submit

June 23, 2017

Conditions

Keywords

ExerciseCognitionNeuroimagingRehabilitationConnectivity

Outcome Measures

Primary Outcomes (1)

  • Change in Verbal Learning and Memory

    Verbal Learning and Memory will be assessed with the Verbal Learning and Memory Test (VLMT)

    Baseline and at Month 3 (end of intervention)

Secondary Outcomes (3)

  • Change in Functional Connectivity

    Baseline and at Month 3 (end of intervention)

  • Change in Structural Connectivity

    Baseline and at Month 3 (end of intervention)

  • Change in Neuropsychological Function

    Baseline and at Month 3 (end of intervention)

Other Outcomes (2)

  • Change in Patient-Reported Outcomes

    Baseline and at Month 3 (end of intervention)

  • Change in Walking Ability

    Baseline and at Month 3 (end of intervention)

Study Arms (2)

Aerobic Exercise (12 Weeks)

EXPERIMENTAL

Aerobic exercise on a bicycle ergometer, tailored to the individual's level of fitness. Duration: 12 weeks with 2-3 sessions per week.

Behavioral: Aerobic Exercise

Waitlist Control Group

NO INTERVENTION

No intervention (patients randomized to this group will be offered access to the training program after completion of the trial)

Interventions

3-months exercise program tailored to the individual level of aerobic fitness. Patients will exercise on a bicycle ergometer (2-3 session per week) according to a predefined training plan with increasing duration and intensity

Aerobic Exercise (12 Weeks)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Relapsing-remitting multiple sclerosis according to McDonald criteria
  • Currently in remission
  • Disease duration \< 10 years
  • Low to moderate physical disability (EDSS 0-3.5)
  • On stable immunotherapy (\>3 months) or without any planned treatment for the next year

You may not qualify if:

  • Patients who are not able to understand the study concept due to severe cognitive deficits or psychiatric comorbidity
  • Patients currently taking psychoactive drugs
  • Patients unable to undergo aerobic exercise training for medical reasons
  • Patients with active disease or uncertain stability under current immunomodulatory therapy (as judged by the treating neurologist)
  • Patients with implants or body modifications (e.g. dental implants, piercings, tattoos, pacemakers etc.) which might interfere with MEG and MRI assessments
  • Patients unable to travel to the study center 2-3 times a week for the duration of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Hamburg-Eppendorf

Hamburg, 20241, Germany

Location

Related Publications (1)

  • Baquet L, Hasselmann H, Patra S, Stellmann JP, Vettorazzi E, Engel AK, Rosenkranz SC, Poettgen J, Gold SM, Schulz KH, Heesen C. Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial. PeerJ. 2018 Dec 12;6:e6037. doi: 10.7717/peerj.6037. eCollection 2018.

MeSH Terms

Conditions

Multiple SclerosisMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Stefan M Gold, PhD

    Center for Molecular Neurobiology, University Hospital Hamburg Eppendorf

    PRINCIPAL INVESTIGATOR
  • Andreas K Engel, MD

    Dept Neurophysiology, University Hospital Hamburg Eppendorf

    PRINCIPAL INVESTIGATOR
  • Christoph Heesen, MD

    Dept Neurology, University Hospital Hamburg Eppendorf

    PRINCIPAL INVESTIGATOR
  • Guido Nolte, PhD

    Dept Neurophysiology, University Hospital Hamburg Eppendorf

    PRINCIPAL INVESTIGATOR
  • Karl-Heinz Schulz, MD, PhD

    Dept Sports Medicine, University Hospital Hamburg Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2013

First Posted

December 9, 2013

Study Start

December 1, 2013

Primary Completion

May 1, 2016

Study Completion

November 1, 2016

Last Updated

June 26, 2017

Record last verified: 2017-06

Locations